Skip to main content

This website uses cookies.

By continuing to use this website, you consent to our use of these cookies. Read more about our use of cookies

I agree
Elocta logotype

Main navigation (without target group)

  • WHAT IS ELOCTA®
  • WHY ELOCTA®
  • HOW TO USE ELOCTA®
  • FOR YOUR PATIENTS
  • FAQ
Jumping in the rain
Elocta® is the first extended half-life recombinant factor VIII approved in the EU
Learn more

Elocta

What is Elocta®

LEARN MORE

Why Elocta®

LEARN MORE

How to use Elocta®

LEARN MORE

Elocta

Elocta® is the first extended half-life recombinant factor VIII approved in the EU
Learn more

What is Elocta®

LEARN MORE

Why Elocta®

LEARN MORE

How to use Elocta®

LEARN MORE
Image

You are about to enter elocta.com.

Please select if you are a healthcare professional or a patient.

I'm a

Professional
Patient

Footer Menu

  • PATIENT SAFETY
  • PRESCRIBING INFORMATION
  • MEDICAL ENQUIRIES
  • TERMS OF USE
  • PRIVACY POLICY
  • SOBI.COM
sobi

The information on this website is intended for Healthcare Professionals (HCPs) only.

© 2019 Swedish Orphan Biovitrum AB (publ) 
All rights reserved  
Sobi and Elocta are trademarks of Swedish Orphan Biovitrum AB (publ). 
All third party trademarks are the property of their respective owners.

Document number: PP-3450
Website updated: 18-05-15

Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, Sweden 
Reg.No. 556038-9321

TEl: +4686972000

E-mail: medical.info@sobi.com